BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• FDA

  WaveLight Receives Wavefront-Guided and Mixed Astigmatism Approval for ALLEGRETTO WAVE(R) Eye-Q

  April 17, 2007

   · 

  1 min read
• Business

  SynCo Bio Partners B.V. Signs Pharmaceutical Service Agreement With ProSensa B.V. for RNA Based Therapeutics for the Treatment of Duchenne Muscular Dystrophy

  April 17, 2007

   · 

  2 min read
• Drug Development

  Northwest Biotherapeutics Files for Authorization for Use of DCVax(R)-Brain for Commercialization in Switzerland

  April 17, 2007

   · 

  6 min read
• Biotech Beach

  Invitrogen Corporation Garners Six Life Science Industry Awards

  April 17, 2007

   · 

  1 min read
• Drug Development

  Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) Discovers Biomarkers Potentially Predictive of Response to VELCADE(R) (Bortezomib) for Injection

  April 17, 2007

   · 

  8 min read
• Business

  Affymetrix (Santa Clara, California) and NuGEN Technologies, Inc. Announce Agreement to Co-market the NuGEN WT-Ovation(TM) FFPE System

  April 17, 2007

   · 

  1 min read
• Drug Development

  Anadys Pharmaceuticals, Inc. Reports Preclinical Data Showing ANA773 Promotes Anti-Tumor Activity of Natural Killer Cells

  April 17, 2007

   · 

  5 min read
• Drug Development

  Oncolytics Biotech Inc. Research Collaborators Demonstrate Reovirus/Gemcitabine Combination Has Synergistic Effect Against Human Colon Cancer Cell Lines

  April 17, 2007

   · 

  3 min read
• Policy

  Nanogen, Inc. Submits 510(K) for Cystic Fibrosis Genetic Assay and NanoChip(R) 400 System

  April 17, 2007

   · 

  1 min read
• Drug Development

  ProNAi Therapeutics, Inc. Announces Preclinical Success for PNT2258 Therapeutic - Curative Events in Xenograft Mice for Difficult-to-Treat Non-Hodgkin’s Lymphoma

  April 17, 2007

   · 

  1 min read